45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
3,022
Insurances with rates
23
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 682 | RENAL FAILURE WITH MCC | $123,190 | $80,073 | — | — | 32 |
| 289 | ACUTE AND SUBACUTE ENDOCARDITIS WITH CC | $87,322 | $56,760 | — | — | 31 |
| 638 | DIABETES WITH CC | $61,077 | $39,700 | — | — | 32 |
| 808 | MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS | $60,574 | $39,373 | — | — | 32 |
| 073 | CRANIAL AND PERIPHERAL NERVE DISORDERS WITH MCC | $46,319 | $30,107 | — | — | 33 |
| 560 | AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH CC | $42,241 | $27,457 | — | — | 32 |
| 176 | PULMONARY EMBOLISM WITHOUT MCC | $37,362 | $24,285 | — | — | 31 |
| 947 | SIGNS AND SYMPTOMS WITH MCC | $35,687 | $23,197 | — | — | 30 |
| 559 | AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH MCC | $35,591 | $23,134 | — | — | 32 |
| RX-225219 | TENECTEPLASE 50 MG INTRAVENOUS SOLUTION | $34,019 | $22,112 | — | — | 71 |
| RX-1002134 | TENECTEPLASE INJECTION KIT FOR ACUTE ISCHEMIC STROKE (KIT) | $34,019 | $22,112 | — | — | 70 |
| 561 | AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT CC/MCC | $33,322 | $21,659 | — | — | 31 |
| 550 | SEPTIC ARTHRITIS WITHOUT CC/MCC | $27,953 | $18,169 | — | — | 30 |
| 948 | SIGNS AND SYMPTOMS WITHOUT MCC | $27,591 | $17,934 | — | — | 29 |
| 602 | CELLULITIS WITH MCC | $22,336 | $14,519 | — | — | 31 |
| 871 | SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MCC | $21,239 | $13,805 | — | — | 30 |
| 191 | CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH CC | $20,602 | $13,392 | — | — | 30 |
| 689 | KIDNEY AND URINARY TRACT INFECTIONS WITH MCC | $19,440 | $12,636 | — | — | 30 |
| 194 | SIMPLE PNEUMONIA AND PLEURISY WITH CC | $18,661 | $12,130 | — | — | 31 |
| 377 | GASTROINTESTINAL HEMORRHAGE WITH MCC | $18,562 | $12,066 | — | — | 31 |
| 057 | DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MCC | $18,426 | $11,977 | — | — | 38 |
| 603 | CELLULITIS WITHOUT MCC | $17,821 | $11,584 | — | — | 32 |
| 440 | DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITHOUT CC/MCC | $17,654 | $11,475 | — | — | 30 |
| 189 | PULMONARY EDEMA AND RESPIRATORY FAILURE | $17,213 | $11,188 | — | — | 30 |
| 554 | BONE DISEASES AND ARTHROPATHIES WITHOUT MCC | $16,500 | $10,725 | — | — | 31 |
| 949 | AFTERCARE WITH CC/MCC | $16,454 | $10,695 | — | — | 31 |
| 291 | HEART FAILURE AND SHOCK WITH MCC | $16,267 | $10,574 | — | — | 30 |
| RX-129357 | DARBEPOETIN ALFA 500 MCG/ML IN POLYSORBATE INJECTION SYRINGE | $15,867 | $10,314 | — | — | 76 |
| 683 | RENAL FAILURE WITH CC | $14,774 | $9,603 | — | — | 30 |
| 690 | KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC | $14,578 | $9,476 | — | — | 31 |
| 190 | CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MCC | $14,437 | $9,384 | — | — | 30 |
| 392 | ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MCC | $13,349 | $8,677 | — | — | 29 |
| 637 | DIABETES WITH MCC | $13,038 | $8,475 | — | — | 30 |
| RX-245937 | HUMAN PROTHROMBIN CMPX(PCC)-LANS 1,000 UNIT (800-1,280 UNIT) IV SOLUTION | $12,915 | $8,395 | — | — | 55 |
| 193 | SIMPLE PNEUMONIA AND PLEURISY WITH MCC | $12,077 | $7,850 | — | — | 30 |
| 872 | SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC | $10,351 | $6,728 | — | — | 29 |
| 305 | HYPERTENSION WITHOUT MCC | $9,547 | $6,205 | — | — | 30 |
| RX-129721 | DARBEPOETIN ALFA 300 MCG/0.6 ML IN POLYSORBATE INJECTION SYRINGE | $9,520 | $6,188 | — | — | 76 |
| 641 | MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITHOUT MCC | $8,905 | $5,788 | — | — | 31 |
| CASE-36430 | Blood / Products Transfusion per Hour | $8,649 | $5,622 | — | — | 2 |
| RX-196284 | HYDROXOCOBALAMIN 5 GRAM INTRAVENOUS SOLUTION | $7,485 | $4,865 | — | — | 71 |
| RX-209792 | DALBAVANCIN 500 MG INTRAVENOUS SOLUTION | $7,294 | $4,741 | — | — | 74 |
| 309 | CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH CC | $7,002 | $4,552 | — | — | 30 |
| RX-245938 | HUMAN PROTHROMBIN CPLX(PCC)-LANS 500 UNIT (400-640 UNIT) IV SOLUTION | $6,458 | $4,197 | — | — | 55 |
| PX-700001412 | Cta Abd Pelvis Wwo Contrast | $5,812 | $3,778 | — | — | 69 |
| PX-700001393 | CT Abd Pelvis WO Cont Then W Cont | $5,519 | $3,587 | — | — | 70 |
| PX-700000668 | Cta Abd Aorta Bi Iliofem W/WO | $4,674 | $3,038 | — | — | 72 |
| RX-6562 | PROCAINAMIDE 100 MG/ML INJECTION SOLUTION | $4,500 | $2,925 | — | — | 66 |
| PX-700000663 | CT Extremity Lower WO Cont Bi | $4,481 | $2,913 | — | — | 72 |
| PX-700001392 | CT Abd Pelvis With Contrast | $4,417 | $2,871 | — | — | 69 |
Showing top 50 of 3,022 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.